Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950558 · ClinicalTrials.gov registry record · Phase 4
Anesthesia for Pain After Ankle Fracture Surgery
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT02950558 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 14 participants.
The verdict
NCT02950558, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
This pilot study will test the hypothesis that prolonged regional peripheral nerve block will reduce development of chronic pain in patients undergoing surgery for ankle fracture compared to standard of care. Subjects will be followed for one year.
Interventions
- PROCEDURE Nerve block
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2020-06-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950558
The ClinicalTrials.gov registry entry for NCT02950558 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nerve block is the first listed.
NCT02950558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950558 about?
NCT02950558 is a clinical study titled "Anesthesia for Pain After Ankle Fracture Surgery". This pilot study will test the hypothesis that prolonged regional peripheral nerve block will reduce development of chronic pain in patients undergoing surgery for ankle fracture compared to standard of care. Subjects will be followed for one year.
What is the current status of trial NCT02950558?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2018-05-29. Estimated completion is 2020-06-19.
What interventions are being tested in trial NCT02950558?
The interventions under investigation include: Nerve block (PROCEDURE), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02950558?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.